Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials
Related Posts
Li YR, Zhou Y, Yu J, Kim YJ, Li M, Lee D, Zhou K, Chen Y, Zhu Y, Wang YC, Li Z, Yu Y, Dunn[...]
Mayer DP, Neslon ME, Andriyanova D, Filler RB, Ökten A, Antao OQ, Chen JS, Scumpia PO, Weaver WM, Wilen CB, Deshayes S, Weinstein JS. A[...]
Poppens M, Ruci A, Davis J. Cutaneous Applications of the Antiviral Drug Cidofovir: A Review. J Clin Med. 2024 Apr 23;13(9):2462. doi: 10.3390/jcm13092462. PMID: 38730991;[...]